Genetic Counseling Program
Meagan is the Senior Marketing Manager in Population Health at Ambry Genetics where she develops and manages product marketing strategy for population health platforms, identifying and executing key marketing programs with performance metrics. Prior to this role, she was Genetic Counseling Business Manager and Genetic Clinical Operations Director at My Gene Counsel (mGC), LLC (2014-2022).
Meagan Farmer graduated from University of South Florida with a Bachelor of Science in Biomedical Sciences and a minor in Public Health. She received her Master of Science degree from the University of North Carolina at Greensboro Genetic Counseling Program in 2012 and was competitively selected for the Yale Cancer Genetic Counseling Fellowship. As a new graduate, Meagan worked as a cancer, prenatal and general genetic counselor at University of Alabama at Burmingham (UAB), then became Director of Cancer Genetic Counseling in 2013 and Lead Genetic Counselor of Oncology Services in 2018.
Meagan earned an MBA at UAB Collat School of Business in 2017. Her passion and expertise in cancer genetics, public health and education drove her to contribute at the institutional, state and national level on initiatives such as the Cancer Management Team, Telemedicine Advisory Board, Precision Oncology Working Group, Clinical Genetics Systems Committee at UAB as well as the Variant Review Committee of the Alabama Genomic Health Initiative, and Genetics/Familial High-Risk Assessment: Breast and Ovarian Cancer Panel through the National Comprehensive Cancer Network.
Not only has Meagan served on the UAB Genetic Counseling Program’s curriculum committee, but she has been a clinical rotation supervisor, instructor, coursemaster, and has served on multiple thesis committees. She is also Co-Director and Co-Founder of the Cancer Genetic Counseling Fellowship at UAB Genetic Counseling Training Program. Selected presentations and activities include The Kinetix Group Oncology Thought Leaders Network as well as monthly series with Precision Oncology News. Finally, Meagan continues to give back at the community level.
She is a board member of Normal Livingston Ovarian Cancer Foundation and has been a board member for Susan G. Komen North Central Alabama. Meagan’s research interests and grant work is focused on translational cancer genetics research, telemedicine service delivery model and exploring barriers to participation in breast cancer research among African Americans. In 2017, she co-authored a textbook Pediatric Cancer Genetics and has written several book chapters in oncology texts.